Literature DB >> 22691178

Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells.

L A Birder1, A S Wolf-Johnston, Y Sun, T C Chai.   

Abstract

AIM: To examine function of both cholinergic (muscarinic) and TRPV1 receptors in human bladder urothelial (HBUC) from non-neurogenic overactive bladder (OAB) patients as compared to control subjects.
METHODS: Primary HBUC cultures were derived from cystoscopic biopsies from OAB and control subjects. Muscarinic and TRPV1 function was assessed by acetylcholine (5 μm) or capsaicin (0.5 μm) evoked ATP release, measured by luciferase assay. Overall, expression of TRPV1 and muscarinic M3 receptors in bladder urothelial cells was accomplished using western immunoblotting.
RESULTS: Our findings revealed that the response to acetylcholine in OAB HBUC cultures (which was blocked by the nonselective muscarinic antagonist, atropine methyl nitrate or AMN) was not significantly different than from controls. The acetylcholine M3 receptor was slightly decreased as compared to control. In contrast, OAB HBUC cultures exhibited a capsaicin hypersensitivity and augmented release of ATP (3.2 fold higher), which was blocked by the antagonist capsazepine. The increase in capsaicin sensitivity correlated with increased urothelial TRPV1 expression.
CONCLUSION: Though characterized in a small number of subjects, augmented release of urothelial-derived transmitters such as ATP could 'amplify' signalling between and within urothelial cells and nearby afferent nerves.
© 2012 The Authors Acta Physiologica © 2012 Scandinavian Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691178      PMCID: PMC3494763          DOI: 10.1111/j.1748-1716.2012.02462.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  41 in total

Review 1.  Pharmacological agents for the treatment of urinary incontinence due to overactive bladder.

Authors:  A J Wein
Journal:  Expert Opin Investig Drugs       Date:  2001-01       Impact factor: 6.206

Review 2.  The activation of bladder wall afferent nerves.

Authors:  J Morrison
Journal:  Exp Physiol       Date:  1999-01       Impact factor: 2.969

Review 3.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

Review 4.  A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction.

Authors:  David E Rapp; Mark B Lyon; Gregory T Bales; Sean P Cook
Journal:  Eur Urol       Date:  2005-08       Impact factor: 20.096

5.  Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.

Authors:  Yongtae Kim; Naoki Yoshimura; Hitoshi Masuda; Fernando De Miguel; Michael B Chancellor
Journal:  BJU Int       Date:  2006-02       Impact factor: 5.588

Review 6.  Intravesical treatment of overactive bladder.

Authors:  C J Fowler
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

Review 7.  Mechanisms involved in new therapies for overactive bladder.

Authors:  Francisco Cruz
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

Review 8.  Muscarinic receptors in the bladder: from basic research to therapeutics.

Authors:  Sharath S Hegde
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

9.  Non-neuronal cholinergic system in human bladder urothelium.

Authors:  Masaki Yoshida; Akito Inadome; Yoshihiro Maeda; You Satoji; Koichi Masunaga; Yutaka Sugiyama; Shigetaka Murakami
Journal:  Urology       Date:  2006-02       Impact factor: 2.649

10.  Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.

Authors:  C M Brady; A N Apostolidis; M Harper; Y Yiangou; A Beckett; T S Jacques; A Freeman; F Scaravilli; C J Fowler; P Anand
Journal:  BJU Int       Date:  2004-04       Impact factor: 5.588

View more
  16 in total

1.  BDNF-ERK1/2 signaling pathway in ketamine-associated lower urinary tract symptoms.

Authors:  Xiaolong Wang; Biwen Peng; Chang Xu; Zhengyan Gao; Yuanfei Cao; Zhao Liu; Tongzu Liu
Journal:  Int Urol Nephrol       Date:  2016-05-10       Impact factor: 2.370

Review 2.  Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.

Authors:  Donna Sellers; Russ Chess-Williams; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

Review 3.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 4.  TRP channels in lower urinary tract dysfunction.

Authors:  J Franken; P Uvin; D De Ridder; T Voets
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 5.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

6.  Development of stress-induced bladder insufficiency requires functional TRPV1 channels.

Authors:  Nathan R Tykocki; Thomas J Heppner; Cuixia Shi Erickson; Jason van Batavia; Margaret A Vizzard; Mark T Nelson; Gerald C Mingin
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-08

7.  Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium.

Authors:  Ann T Hanna-Mitchell; Amanda S Wolf-Johnston; Stacey R Barrick; Anthony J Kanai; Michael B Chancellor; William C de Groat; Lori A Birder
Journal:  Neurourol Urodyn       Date:  2013-10-26       Impact factor: 2.696

Review 8.  OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.

Authors:  Hann-Chorng Kuo
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

Review 9.  Transient receptor potential cation channels in visceral sensory pathways.

Authors:  L Ashley Blackshaw
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

10.  VEGF induces sensory and motor peripheral plasticity, alters bladder function, and promotes visceral sensitivity.

Authors:  Anna P Malykhina; Qi Lei; Chris S Erickson; Miles L Epstein; Marcia R Saban; Carole A Davis; Ricardo Saban
Journal:  BMC Physiol       Date:  2012-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.